Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;19(9):974-9.
doi: 10.1097/GME.0b013e31824ac071.

Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women

Affiliations

Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women

Jill A Marrone et al. Menopause. 2012 Sep.

Abstract

Objective: Epidemiological studies indicate that higher bone mass is associated with moderate alcohol consumption in postmenopausal women. However, the underlying cellular mechanisms responsible for the putative beneficial effects of alcohol on bone are unknown. Excessive bone turnover, combined with an imbalance whereby bone resorption exceeds bone formation, is the principal cause of postmenopausal bone loss. This study investigated the hypothesis that moderate alcohol intake attenuates bone turnover after menopause.

Methods: Bone mineral density was determined by dual-energy x-ray absorptiometry in 40 healthy postmenopausal women (mean ± SE age, 56.3 ± 0.5 y) who consumed alcohol at 19 ± 1 g/day. Serum levels of the bone formation marker osteocalcin and the resorption marker C-terminal telopeptide (CTx) were measured by immunoassay at baseline (day 0) and after alcohol withdrawal for 14 days. Participants then consumed alcohol and were assayed on the following morning.

Results: Bone mineral density at the trochanter and total hip were positively correlated to the level of alcohol consumption. Serum osteocalcin and CTx increased after abstinence (4.1 ± 1.6%, P = 0.01 and 5.8 ± 2.6%, P = 0.02 compared with baseline, respectively). Osteocalcin and CTx decreased after alcohol readministration, compared with the previous day (-3.4 ± 1.4%, P = 0.01 and -3.5 ± 2.1%, P = 0.05, respectively), to values that did not differ from baseline (P > 0.05).

Conclusions: Abstinence from alcohol results in increased markers of bone turnover, whereas resumption of alcohol reduces bone turnover markers. These results suggest a cellular mechanism for the increased bone density observed in postmenopausal moderate alcohol consumers. Specifically, the inhibitory effect of alcohol on bone turnover attenuates the detrimental skeletal consequences of excessive bone turnover associated with menopause.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest.

Figures

Figure 1
Figure 1
Total hip (A), trochanter (B), femoral neck (C), and lumbar spine (D) BMD versus quantity of alcohol intake in early postmenopausal women. Please note the significant positive association between alcohol intake and total hip BMD (A) and trochanter BMD (B). N = 39 for femur and 40 for lumbar spine.
Figure 2
Figure 2
Mean percent change in serum osteocalcin (A), a marker of bone formation and serum CTx (B), a marker of bone resorption, following 14 days of abstinence from alcohol and subsequent restoration of alcohol intake to pre-abstinence levels. Please note that a relatively brief interval of abstinence (14 days) resulted in significant increases in serum osteocalcin and CTx whereas resumption of alcohol consumption resulted in an overnight decrease in serum osteocalcin and CTx to levels that did not differ from baseline (day 0). Values are mean ± SE; N = 40 for each time interval. ap ≤ 0.05 compared to Day 0; bp ≤ 0.05 compared to Day 14.

Comment in

  • Hard stuff for the bones.
    Simoncini T, Genazzani AR. Simoncini T, et al. Menopause. 2012 Sep;19(9):954-5. doi: 10.1097/gme.0b013e318264aef0. Menopause. 2012. PMID: 22922512 No abstract available.

Similar articles

Cited by

References

    1. Melton LJ, 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH, 3rd, Einhorn TA, Johnston CC, Raisz LG, Silverman SL, Siris ES. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:16–23. - PubMed
    1. Garnero P, Delmas PD. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact. 2004;4:50–63. - PubMed
    1. Hosam K. Postmenopausal osteoporosis: etiology, current diagnosis, strategies, and nonprescription interventions. J Manag Care Pharm. 2006;12:S4–S9. - PMC - PubMed
    1. Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, Tanko LB. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol. 2006;62:781–792. - PubMed
    1. General S U.S. Department of Health and Human Services. Services USDoHaH, editor. Rockville, MD: 2004. Bone Health and Osteoporosis: A Report of the Surgeon General.

Publication types